Hunsche E
No ORCID on file
· 5 papers in corpus
observational
2026
Elke Hunsche,1 Viatcheslav G Rakov,1 Jennifer Coppola,2 Sanjay K Agarwal31Formerly at Sumitomo Pharma Switzerland GmbH, Basel, Switzerland; 2Formerly at Sumitomo Pharma America Inc., Cambridge, MA, USA; 3Department of OBGYN & Reproductive S…
observational
2026
PURPOSE: To characterize the experiences of individuals taking hormonal therapies to manage their symptoms of endometriosis (EM) or uterine fibroids (UF). PATIENTS AND METHODS: This prospective, 16-week observational study enrolled US part…
rct
2024
OBJECTIVE: To evaluate the effect of relugolix combination therapy (relugolix CT; 40 mg relugolix, 1 mg estradiol, and 0.5 mg norethisterone acetate) for up to 2 years in the SPIRIT long-term extension study on functioning and health-relate…
observational
2024
PURPOSE: To characterize the burden of uterine fibroids (UF) in individuals experiencing heavy menstrual bleeding (HMB) and moderate-to-severe UF-associated pain in terms of symptoms experienced, impact on work and activities, and pain medi…
qualitative
2023
Elke Hunsche,1 Martha Gauthier,2 Brooke Witherspoon,2 Viatcheslav Rakov,1 Sanjay K Agarwal3 1Myovant Sciences GmbH, Basel, Switzerland; 2Endpoint Outcomes, A Lumanity Company, Boston, MA, USA; 3Center for Endometriosis Research and Treatmen…